Boudewijn L DeJonge
- Molecular Medicine top 2%
- Pharmacology top 10%
- Molecular Biology
- Infectious Diseases top 10%
- Epidemiology
- Co-authors
- Beatriz Meurer MoreiraSusan Boyle‐VavraRobert S. DaumDavid E. EhmannAlita A. MillerR.A. GiacobbeMichael D. HubandRong-Fang Gu
- Topics
- Antibiotic Resistance in Bacteria (10 papers)Antibiotics Pharmacokinetics and Efficacy (4 papers)Cancer therapeutics and mechanisms (2 papers)
- Journals
- Journal of Clinical MicrobiologyJournal of Medicinal ChemistryAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Boudewijn L DeJonge
11 papers receiving 369 citations
Peers
Comparison fields: 5 of 48
- Molecular Medicine 225
- Pharmacology 144
- Molecular Biology 143
- Infectious Diseases 132
- Epidemiology 80
Countries citing papers authored by Boudewijn L DeJonge
This map shows the geographic impact of Boudewijn L DeJonge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boudewijn L DeJonge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boudewijn L DeJonge more than expected).
Fields of papers citing papers by Boudewijn L DeJonge
This network shows the impact of papers produced by Boudewijn L DeJonge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boudewijn L DeJonge. The network helps show where Boudewijn L DeJonge may publish in the future.
Co-authorship network of co-authors of Boudewijn L DeJonge
This figure shows the co-authorship network connecting the top 25 collaborators of Boudewijn L DeJonge. A scholar is included among the top collaborators of Boudewijn L DeJonge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boudewijn L DeJonge. Boudewijn L DeJonge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 2 | |
| 8 | 4 | |
| 9 | 183 | |
| 10 | 86 | |
| 11 | 105 |
About Boudewijn L DeJonge
Boudewijn L DeJonge is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 11 papers that have together received 393 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Molecular Medicine (225 citations), Applied Microbiology and Biotechnology (51 citations) and Pharmacology (144 citations). Boudewijn L DeJonge has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Beatriz Meurer Moreira, Susan Boyle‐Vavra, Robert S. Daum, David E. Ehmann, Alita A. Miller, R.A. Giacobbe, Michael D. Huband, Rong-Fang Gu, Adam B. Shapiro and William F. Penwell. Their work appears in journals such as Journal of Clinical Microbiology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.